<qa>  What is the aim of the Bio-bank and Registry for StratIfication and TargetThe Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes BRITE-SPOT has been set up to prospectively collect clinical data and biologically relevant samples from individuals with, and at risk for type 2 diabetes T2D, with the aim of delineating factors related to susceptibility, progression, complications and response to treatment. Expanded from BRITE-SPOT, Assessing the Progression to Type - 2 Diabetes APT-2D is a prospective cohort with a focus on non-diabetics normoglycemic or prediabetic, to expand the sample size and depth of metabolic phenotyping in these upstream groups, with the more targeted aim of delineating factors related to insulin sensitivity versus secretion, that relate to progression to T2D. 